Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-25-152827
Filing Date
2025-06-30
Accepted
2025-06-30 16:52:12
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d933055d424b5.htm 424B5 501791
2 GRAPHIC g933055g55k01.jpg GRAPHIC 48089
3 GRAPHIC g933055g67o79.jpg GRAPHIC 50066
  Complete submission text file 0001193125-25-152827.txt   638421
Mailing Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158
Business Address 455 MISSION BAY BOULEVARD SOUTH SAN FRANCISCO CA 94158 4154825300
NEKTAR THERAPEUTICS (Filer) CIK: 0000906709 (see all company filings)

EIN.: 943134940 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-286222 | Film No.: 251092834
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)